Astellas Pharma Vs. Nxera Pharma Industry Stock Comparison

Sell

41

ALPMY
Astellas Pharma

Last Price:

$9.79

Seasonality Move:

2.7%

Sell

18

SOLTF
Nxera Pharma

Last Price:

$6.16

Seasonality Move:

16.5%

Sell

41

Astellas Pharma (ALPMY) is a Sell

Is Astellas Pharma a Buy, Sell or Hold?

The current Astellas Pharma [ALPMY] share price is $9.79. The Score for ALPMY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
ALPMY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

18

Nxera Pharma (SOLTF) is a Sell

Is Nxera Pharma a Buy, Sell or Hold?

The current Nxera Pharma [SOLTF] share price is $6.16. The Score for SOLTF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
SOLTF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

ALPMY Stock Price Chart

What is Astellas Pharma's stock price today?

The Astellas Pharma share price today is $9.79

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALPMY is experiencing slight buying pressure.

SOLTF Stock Price Chart

What is Nxera Pharma's stock price today?

The Nxera Pharma share price today is $6.16

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.

ALPMY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.3	Sell
Relative Strength Index (14 RSI):	32.33	Sell
Chaikin Money Flow:	72172	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(9.92 - 10.54)	Sell
Bollinger Bands (100):	(10.59 - 12.19)	Sell

SOLTF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.36	Sell
Relative Strength Index (14 RSI):	9.27	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(6.92 - 8.02)	Sell
Bollinger Bands (100):	(7.42 - 9.5)	Sell

ALPMY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	9.93	Sell
20-day SMA:	10.22	Sell
50-day SMA:	10.84	Sell
200-day SMA:	10.75	Sell
8-day EMA:	9.91	Sell
20-day EMA:	10.2	Sell
50-day EMA:	10.67	Sell
200-day EMA:	11.17	Sell

SOLTF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	6.78	Sell
20-day SMA:	7.32	Sell
50-day SMA:	7.63	Sell
200-day SMA:	9.21	Sell
8-day EMA:	6.77	Sell
20-day EMA:	7.17	Sell
50-day EMA:	7.68	Sell
200-day EMA:	9.01	Sell

Astellas Pharma Earnings Growth & ALPMY Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nxera Pharma Earnings Growth & SOLTF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Astellas Pharma Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nxera Pharma Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):